====== Drug Information Association ======

{{ ::fdownload.png?200|}}

The **Drug Information Association (DIA)** is an international non-profit organization based in [[united_states:Washington, D.C.]]

===== History =====

On October 10, 1962, U.S. President [[John F. Kennedy]] signed into law the Kefauver-Harris amendments to the [[US Federal Food, Drug, and Cosmetics Act of 1938]], following the discovery that [[thalidomide]] cause birth defects in babies of pregnant mothers who took the drug for [[morning sickness]].((Turner, J. R. (2017). //DIA Then and Now: A Half-Century Odyssey.// Therapeutic Innovation & Regulatory Science, 51(5), 531–533. https://doi.org/10.1177/2168479017725516))

The DIA was founded in 1964, a move "closely tied" to the sweeping amendments.((//DIA Releases Results of Patient Engagement in Drug Development Study.// (2016, November 14). DIA Global. https://web.archive.org/web/20221021102452/https://www.diaglobal.org/en/resources/press-releases/2016/10-31-patient-engagement-study))

===== Organization =====

==== Personnel ====

^  DIA Team  ^^^
^ Name  ^ Position  ^ Notes  ^
^  Board of Directors((//Board of Directors.// DIA Global. Retrieved October 30, 2021, from http://archive.today/2021.10.30-045042/https://www.diaglobal.org/en/about-us/leadership-governance/Board-of-Directors?Committeeid=30000038))  ^^^
| [[Cynthia Verst]]  | Chair  | [[IQVIA]], [[OptumInsight]]  |
| [[Judith Ng-Cashin]]  | Immediate Past Chair  | [[pharmaceutical_companies:Eagle Pharmaceuticals]], [[pharmaceutical_companies:AOBiome Therapeutics]], [[Syneos Health]]  |
| [[Michael Rosenblatt]]  | Chair-Elect  | [[Flagship Pioneering]], [[pharmaceutical_companies:Merck]], [[Tufts Medical School]], [[Harvard University]], [[Beth Israel Deaconess Medical Center]], [[Harvard-MIT Program in Health Sciences and Technology]] (HST), [[Harvard Medical School]], [[Massachusetts General Hospital]], [[Brigham and Women's Hospital]], [[Boston Children's Hospital]]  |
| [[Michael Romano]]  | Secretary/Treasurer  | [[RSM]]  |
| [[Junaid Bajwa]]  | Director  | [[Microsoft Research]], [[National Health Service]] (NHS), [[University College London]] (UCL), [[Harvard T.H. Chan School of Public Health]]  |
| [[Michael Devoy]]  | Director  | [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Schering]], [[Royal College of Physicians]], [[pharmaceutical_companies:GlaxoSmithKline]]  |
| [[Marwan Fathalla]]  | President and Global Chief Executive  | [[medical_technology_companies:Ortho Clinical Diagnostics]], [[Avantor]], [[pharmaceutical_companies:Danaher]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Hospira]], [[pharmaceutical_companies:Abbott]]  |
| [[Peter Honig]]  | Director  | [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Merck]], [[Food and Drug Administration]] (FDA), [[Center for Drug Evaluation and Research]] (CDER), [[Pharmaceutical Research and Manufacturers of America]] (PhRMA), [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[American Society for Clinical Pharmacology and Therapeutics]] (ASCPT)  |
| [[Frank Jiang]]  | Director  | -  |
| [[Tatyana Kosheleva]]  | Director  | [[pharmaceutical_companies:Amring Pharmaceuticals]]  |
| [[Peter Sorger]]  | Director  | [[Harvard Medical School]], [[Massachusetts Institute of Technology]] (MIT), [[pharmaceutical_companies:Merrimack Pharmaceuticals]], [[Glencoe Software]]  |
| [[Kihito Takahashi]]  | Director  | [[Mirasense Partners]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:LOTUS Pharmaceutical]], [[pharmaceutical_companies:GlaxoSmithKline]], [[BONAC Corporation]], [[International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine]] (IFAPP), [[European Federation of Pharmaceutical Industries and Associations]] (EFPIA), [[Japanese Association of Pharmaceutical Medicine]] (JAPhMed)  |
| [[Karin Van Baelen]]  | Director  | [[pharmaceutical_companies:Janssen]]  |
| [[Rachel Zhang]]  | Director  | [[McKinsey & Company]], [[New Path Global]], [[pharmaceutical_companies:Merck]]  |
| [[Jason Monteleore]]  | Observer  | [[Ancillare]], [[dMed-Clinipace]], [[Clinipace]], [[Pivotal Financial Consulting]], [[Theorem Clinical Research]]  |
^  Executive Leadership((//Executive Leadership Team.// DIA Global. Retrieved May 28, 2023, from http://archive.today/2023.05.28-201837/https://www.diaglobal.org/en/about-us/leadership-governance/Executive-Leadership-Team))  ^^^
| Marwan Fathalla  | President and Global Chief Executive  | [[medical_technology_companies:Ortho Clinical Diagnostics]], [[Avantor]], [[pharmaceutical_companies:Danaher]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Hospira]], [[pharmaceutical_companies:Abbott]]  |
| [[Jack Foster]]  | Chief Financial Officer  | [[pharmaceutical_companies:Wyeth]], [[pharmaceutical_companies:Auxilium Pharmaceuticals]], [[InClinica]]  |
| [[Courtney Granville]]  | Director of Scientific Affairs  | -  |
| [[Timothy Hess]]  | Vice President of IT  | [[Thomas Publishing Company]], [[Content Data Solutions]], [[Reed Technology & Information Services]]  |
| [[Katie Hill]]  | Senior Vice President & Managing Director of Learning & Digital Solutions  | [[Steve Ogden]], [[Food and Drug Administration]] (FDA)  |
| [[Anna McDermott-Vitak]]  | Senior Vice-President & Managing Director of DIA Americas  | [[Association for Accessible Medicines]], [[pharmaceutical_companies:Amgen]], [[Catholic Coalition for Special Education]]  |
| [[Ania Mitan]]  | Senior Vice President & Managing Director of DIA EMEA, India and Singapore  | [[pharmaceutical_companies:Celgene]], [[pharmaceutical_companies:Eli Lilly]]  |
| [[Shogo Nakamori]]  | Senior Vice President & Managing Director of DIA Japan  | [[Ministry of Health, Labour and Welfare of Japan]], [[Ministry of Education, Culture, Sports, Science and Technology]] (MEXT)  |
| [[Katie Truong]]  | Vice President of People & Culture  | [[New York University Stern School of Business]]  |
| [[Tong-Yan Wang]]  | Senior Vice President & Managing Director of DIA China  | [[Sanpower Group]], [[pharmaceutical_companies:Xian Janssen]], [[Xi'an Medical University]]  |
^  Council of Regulators((//Council of Regulators.// DIA Global. Retrieved September 25, 2021, from https://web.archive.org/web/20210925084443/https://www.diaglobal.org/en/about-us/leadership-governance/Council-of-Regulators?Committeeid=42268555))  ^^^
| [[Peter Bachmann]]  | Chair, Fellow of the DIA  | [[European Union Network Data Board]] (EUNDB), [[European Medicines Agency]] (EMA), [[Heads of Medicines Agencies]] (HMA), [[International Pharmaceutical Regulators Programme]] (IPRP), [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[Institute for Pharmaceutical Biology]] (IPB), [[Federal Institute for Drugs and Medical Devices]] (BfArM)  |
| [[Melanie Carr]]  | Member  | [[European Medicines Agency]] (EMA)  |
| [[Gerald Dal Pan]]  | Member  | [[Center for Drug Evaluation and Research]] (CDER), [[WHO Advisory Committee on Safety of Medicinal Products]] (ACSMP), [[Council for International Organizations of Medical Sciences]] (CIOMS), [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[Johns Hopkins University]]  |
| [[Rogério Gaspar]]  | Member  | [[World Health Organization]] (WHO), [[Faculty of Pharmacy, University of Lisbon]], [[European Medicines Agency]] (EMA), [[Infarmed]], [[International Narcotics Control Board]] (INCB)  |
| [[Yee Hoo Looi]]  | Member  | [[Health Sciences Authority]] (HSA)  |
| [[Celia Lourenco]]  | Member  | [[Biologics and Radiopharmaceutical Drugs Directorate]] (BRDD), [[Health Canada]], [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[International Pharmaceutical Regulators Programme]]  |
| [[Younjoo Park]]  | Member  | [[Ministry of Food and Drug Safety]]  |
| [[Jörg Schläpfer]]  | Member  | [[Swissmedic]], [[University of Bern]]  |
| [[Hiroshi Suzuki]]  | Member  | [[Pharmaceutical and Medical Devices Agency]] (PMDA), [[University of Tokyo]], [[University of Tokyo Hospital]]  |
^  Science and Policy Advisory Council((//Science and Policy Advisory Council.// DIA Global. Retrieved May 28, 2023, from http://archive.today/2023.05.28-202645/https://www.diaglobal.org/en/about-us/leadership-governance/Science-and-Policy-Advisory-Council?Committeeid=42411336))  ^^^
| [[Clark Golestani]]  | Chair  | [[C Sensei Group]], [[New Mountain Capital]], [[CXO Fund]], [[Dell Medical School]], [[Sparta Systems]], [[CIOX Health]], [[eMids]], [[TruU]], [[UMGC Ventures]], [[Zapata Computing]], [[pharmaceutical_companies:Merck]], [[Oracle]]  |
| Peter Sorger  | Co-chair  | [[Harvard Medical School]], [[Massachusetts Institute of Technology]] (MIT), [[pharmaceutical_companies:Merrimack Pharmaceuticals]], [[Glencoe Software]]  |
| [[Andy Beck]]  | Member  | [[American Board of Pathology]], [[PathAI]], [[Harvard Medical School]], [[Beth Israel Deaconess Medical Center]]  |
| [[Jennifer Levin Carter]]  | Member  | [[Sandbox Healthcare]], [[Blue Venture Fund]], [[TrialzOWN]], [[N-of-One]]  |
| [[Andy Coravos]]  | Member  | [[HumanFirst]], [[Harvard-MIT Center for Regulatory Sciences]] (CRS), [[Food and Drug Administration]] (FDA), [[Digital Medicine Society]] (DiMe), [[DEF CON Biohacking Village]]  |
| [[Nancy Dreyer]]  | Fellow of DIA  | [[IQVIA]], [[University of North Carolina at Chapel Hill]], [[International Society of Pharmaceoepidemiology]]  |
| [[Susanne Gronen]]  | Member  | [[pharmaceutical_companies:Astellas]]  |
| [[Natalija Jovanovic]]  | Member  | [[pharmaceutical_companies:Sanofi Pasteur]], [[American International Group]] (AIG), [[Brown Brothers Harriman]], [[McKinsey & Company]], [[Massachusetts Institute of Technology]] (MIT)  |
| [[Yeul Hong Kim]]  | Member  | [[Korea University College of Medicine]], [[Asian Clinical Oncology Society]] (ACOS)
| [[Sandy Milligan]]  | Fellow of DIA  | [[pharmaceutical_companies:Organon]], [[pharmaceutical_companies:Merck]]
| Michael Rosenblatt  | Member  | [[Flagship Pioneering]], [[pharmaceutical_companies:Merck]], [[Tufts Medical School]], [[Harvard University]], [[Beth Israel Deaconess Medical Center]], [[Harvard-MIT Program in Health Sciences and Technology]] (HST), [[Harvard Medical School]], [[Massachusetts General Hospital]], [[Brigham and Women's Hospital]], [[Boston Children's Hospital]]  |
| [[Birgit Schoeberl]]  | Member  | [[pharmaceutical_companies:Novartis]], [[Massachusetts Institute of Technology]] (MIT)  |
| [[Ling Su]]  | Fellow of DIA  | [[Shenyang Pharmaceutical University]], [[Lilly Asia Ventures]] (LAV), [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Wyeth]], [[pharmaceutical_companies:Novartis]], [[Center for Drug Evaluation and Research]] (CDER)  |
| [[Robert Califf]]  | Advisor  | [[Food and Drug Administration]] (FDA)  |
| [[Sandra Horning]]  | Advisor  | [[pharmaceutical_companies:EQRx]], [[pharmaceutical_companies:Genentech]], [[pharmaceutical_companies:Roche]], [[Stanford University School of Medicine]]  |
^  Patient Advisory Council((//Patient Advisory Council.// DIA Global. Retrieved May 28, 2023, from https://web.archive.org/web/20230528210555/https://www.diaglobal.org/en/about-us/leadership-governance/Patient-Advisory-Council?Committeeid=42411337))  ^^^
| Junaid Bajwa  | Co-chair  | [[Microsoft Research]], [[National Health Service]] (NHS), [[University College London]] (UCL), [[Harvard T.H. Chan School of Public Health]]  |
| [[Kevin Loth]]  | Co-chair  | [[WDLBio]], [[pharmaceutical_companies:Celgene]], [[EBE-EuropaBio Taskforce on Rare Diseases]], [[EU Committeee of Experts on Rare Diseases]], [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA), [[pharmaceutical_companies:Novartis]], [[National Health Service]] (NHS)  |
| [[Nicola Bedlington]]  | Member  | [[European Patients Forum]] (EPF), [[European Commission]], [[European Disability Forum]], [[Environment and School Initiatives]] (ENSI)  |
| [[Daiming Fan]]  | Member  | [[Chinese Anti-Cancer Association]], [[Asian Pacific Association of Gastroenterology]], [[World Gastroenterology Organization]], [[Union for International Cancer Control]] (UICC)  |
| [[Patricia Furlong]]  | Member  | [[Parent Project Muscular Dystrophy]] (PMDD)  |
| [[Kenneth Ketz]]  | Fellow of DIA  | [[Tufts Center for the Study of Drug Development]] (CSDD), [[Center for Information and Study on Clinical Research Participation]] (CISCRP), [[CenterWatch]]  |
| [[Yves Juillet]]  | Fellow of DIA  | [[Foundation of the French Academy of Medicine]], [[French Academy of Medicine]], [[European Federation of Pharmaceutical Industries and Associations]] (EFPIA), [[International Federation of Pharmaceutical Manufacturers & Associations]] (IFPMA), [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[Ministry of Solidarity and Health]]  |
| [[Alastair Kent]]  | Member  | [[Genetic Alliance UK]], [[Royal Society of Arts]], [[Department of Health and Social Care]], [[NHS England]]  |
| [[Amy Miller]]  | Member  | [[PhRMA Foundation]], [[Society for Women's Health Research]] (SWHR), [[Personalized Medicine Coalition]] (PMC), [[National Institutes of Health]] (NIH), [[American Association for the Advancement of Science]] (AAAS), [[Jay Rockefeller]]  |
| [[Theresa Mullin]]  | Member  | [[Center for Drug Evaluation and Research]] (CDER), [[Rare Disease Cures Accelerator]], [[International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]] (ICH), [[Reagan-Udall Foundation for the Food and Drug Administration]], [[Food and Drug Law Institute]] (FDLI)  |
| [[Junko Sato]]  | Member  | [[Pharmaceuticals and Medical Devices Agency]] (PMDA), [[Food and Drug Administration]] (FDA), [[European Medicines Agency]] (EMA)  |
| [[Jessica Scott]]  | Member  | [[Legacy Health Strategies]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Takeda]]  |
| [[Jeffrey Sherman]]  | Fellow of IDA  | [[pharmaceutical_companies:Horizon Therapeutics]], [[pharmaceutical_companies:IDM Pharma]], [[pharmaceutical_companies:Takeda]], [[pharmaceutical_companies:NeoPharm]], [[pharmaceutical_companies:Searle]], [[pharmaceutical_companies:Pharmacia]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[Clinical Trials Transformation Initiative]] (CTTI), [[Global Genes]], [[Center for Information and Study on Clinical Research Participation]] (CISCRP)  |
| [[Marshall Summar]]  | Member  | [[Children's National Hospital]], [[Vanderbilt University]]  |
| [[Rebecca Vermeulen]]  | Member  | [[pharmaceutical_companies:Roche]], [[Patient Focused Medicines Development]] (PFMD), [[Healthcare Businesswomen's Association]]  |
| Cynthia Verst  | Member  | [[IQVIA]], [[OptumInsight]]  |

===== External links =====

  * [[https://www.linkedin.com/company/dia/|LinkedIn]]
  * [[https://www.diaglobal.org/|Website]]